Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

Actually, the Generex proceedings have been progre

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36563
(Total Views: 428)
Posted On: 10/21/2022 4:11:12 PM
Posted By: Assiduous
Re: hylander #35889
Actually, the Generex proceedings have been progressing quite rapidly. The last bankruptcy stock I owned took over ten years to complete. Like Generex, a Stalking Horse bought all the assets, for $500,000,000 and then took the company private. We stockholders got half billion in cash and all the debt. Then the creditors swooped in. For ten years, right to the very end, the monthly balance sheet show “Stockholders’ Equity” in the millions of dollars, starting at $500 mil and then slowly being reduced, as creditors carved out their share. In the end, the lawyers got over $50,000,000 and the shareholders got $0.00. http://www.kccllc.net/chesapeake

The outcome for the GNBT shares has an inevitable conclusion. For those who bought GNBT stock after the NuGenerex shares were given out, I also know your pain for I too bought more GNBT shares and will see nothing in return. Thus is the risk one takes when buying OTC stock, especially for under $1 pps.

But for those of us that do own NGIO(NUGX) shares, we can feel lucky that Joe did create Nugenerex as a separate corporation and move the most valuable assets under its control. Had that not happened, then the Stalking Horse would be paying $1.5 mil for all of Generex valuable assets, and we would definitely get nothing.

So, we should know early next year if/how much our NGIO is worth and hopefully get a complete report on where and how the new majority shareholder(s) will use and develop NuGenerex assets.

Considering that the first bankruptcy document was filed April 23rd of this year, I’d say less than a full year to have an outcome is way better than 10 years.


(1)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us